版本:
中国

BRIEF-FDA approves Genentech's MS drug Ocrevus

March 28 Roche Holding Ag

* FDA approves Genentech's Ocrevus (ocrelizumab) for relapsing and primary progressive forms of multiple sclerosis

* Ocrevus will be available to people in U.S. within two weeks

Source text for Eikon:

Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐